RNS Number : 9573D
Volvere PLC
26 June 2023
 

 

-

26 June 2023

Volvere Logo

Volvere plc

("Volvere" or the "Company")

Result of AGM

Volvere announces that all the resolutions proposed at the Annual General Meeting of the Company, held earlier today, were duly passed.

The following proxy votes were received in relation to each resolution:

Resolution

For

Against

Withheld

Resolution 1 - To re-appoint Nicholas Lander as a Director

563,903

43

0

Resolution 2 - To re-appoint David Buchler as a Director

563,903

43

0

Resolution 3 - To receive and consider the Company's accounts for the financial year ended 31 December 2022

563,925

21

0

Resolution 4 - To re-appoint James Cowper Kreston Audit as auditor

563,664

279

0

Resolution 5 - To authorise the Company's audit committee to determine the remuneration of the auditor

563,859

54

        33

Resolution 6 - THAT the Directors be authorised for the purposes of Section 551 of the Companies Act 2006 to allot equity securities

563,622

53

       238

Resolution 7 - THAT the investing strategy of the Company as set out in the Circular be and is hereby approved

563,647

50

       249

Resolution 8 - THAT the Directors be empowered to allot equity securities (as defined in section 560 of the Act) wholly for cash

559,333

4,064

       382

Resolution 9 - THAT the Company be authorised to make one or more market purchases of Ordinary Shares

561,722

      2,003

87

 

For further information contact:

Volvere plc

Jonathan Lander, CEO 

www.volvere.co.uk

 

Tel: +44 (0) 1926 335700

 

Cairn Financial Advisers LLP (Nominated Adviser)

Sandy Jamieson / James Caithie

 

Tel: + 44 (0) 207 213 0880

 

Canaccord Genuity Limited (Joint Broker)

Bobbie Hilliam

 

Tel: + 44 (0) 207 523 8000

 

Hobart Capital Markets LLP (Joint Broker)

Lee Richardson

 

Tel: + 44 (0) 207 070 5691

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGFLFSRRRIRFIV